Nucleic Acid Amplification Testing (NAAT) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Nucleic Acid Amplification Testing (NAAT) Market is Segmented by Technique (Target Amplification, Probe Amplification, and Signal Amplification), Application (Infectious Disease, Cancer, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Nucleic Acid Amplification Testing (NAAT) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Nucleic Acid Amplification Testing Industry Overview

The nucleic acid amplification testing (NAAT) market is moderately fragmented. The factors owing to the competition include rising infectious diseases, the rising launch of products, and rising partnerships between key players, among others. Some of the market players are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Grifols SA, Hoffmann-La Roche Ltd., Hologic Inc., and Illumina Inc

Nucleic Acid Amplification Testing Market Leaders

  1. bioMérieux SA

  2. Hoffmann-La Roche Ltd

  3. Abbott Laboratories

  4. Bio-Rad Laboratories, Inc.

  5. Grifols SA

  6. *Disclaimer: Major Players sorted in no particular order
Nucleic Acid Amplification Testing Market Concentration

Nucleic Acid Amplification Testing (NAAT) Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?